ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2611

Do Patients with Psoriatic Arthritis Fall Into Distinct Clinical Sub-Groups- a Cluster Analysis?

Arane Thavaneswaran1, Vinod Chandran2 and Dafna D. Gladman3, 1Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 2Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Psoriatic Arthritis and Spondyloarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To determine if demographic and disease characteristics of patients with PsA at presentation to a PsA clinic cluster into distinct groups.

Methods: 1058 patients with Psoriatic Arthritis (PsA) were included from an observational cohort. Cluster analysis using Ward’s method was conducted to identify groups of patients based on the following characteristics at baseline:  gender, type of psoriasis (type I or II), duration of PsA, race, family history of psoriasis, ESR, severe PASI, psoriasis vulgaris, nail disease, dactylitis, swollen joint count, damage joint count, axial disease, and presence of arthritis prior to psoriasis. 7 clusters were formed and matched to non-overlapping arthritis patterns (as described previously) at first clinic visit:  distal arthritis, oligoarthritis, polyarthritis, axial only, distal arthritis and axial, oligoarthritis & axial, and polyarthritis & axial. Comparisons between the clusters and arthritis patterns were conducted using t-tests and Chi-square analysis.

Results: The baseline characteristics of the 1058 patients were as follows: 613 (56.5%) males, mean age at diagnosis of PsA 37.1 (13.5) years, mean age at first visit 44 (13.1) years, mean duration of PsA 6.8 (8.2) years, mean active joint count 11.0 (9.8), mean PASI 5.8 (8.3), mean Steinbrocker score 12.9 (25.5), HLA-B*27 116(17.7%)] with an average follow-up of 8.4 (8.4) years. Two main clusters of patients were identified. One consisted of distal arthritis, oligoarthritis and polyarthritis and the other of axial only, distal and axial, oligoarthritis & axial, and polyarthritis & axial, thus clearly identifying patients into peripheral and axial disease. Comparison of the two clusters showed a longer duration of PsA at baseline, more patients with a family history of psoriasis, and more dactylitis in patients with peripheral disease. Patients falling into the axial disease cluster had a higher prevalence of males, more Caucasians, more psoriasis vulgaris, worse PASI score), higher damage joint count and more patients who developed arthritis first.

Conclusion: Based on patients’ characteristics at baseline, cluster analysis separated PsA patients into two main arthritis patterns- axial and peripheral. The study provides further evidence to classify patients into just two groups based on the presence or absence of axial arthritis.

 Table: Comparison of two clusters

Variable

Frequency (%) or Mean (sd)

p-value

Cluster I

Cluster II

Age at diagnosis of Ps (>40 vs. <=40)

63 (14.5%)

47 (20.4%)

0.06

Duration of PsA

8.6 (7.6)

5.0 (6.5)

<0.0001

Gender (Males)

259 (59.4%)

175 (76.1%)

<0.0001

Race (Caucasian vs. others)

365 (84.1%)

208 (90.8%)

0.02

Family history of Psoriasis

124 (28.6%)

33 (14.4%)

<0.0001

Nail disease

214 (69.7%)

120 (78.4%)

0.06

Dactylitis

236 (54.4%)

80 (34.8%)

<0.0001

Abnormal skin

352 (82.4%)

213 (94.3%)

<0.0001

Severe PASI (>=10)

35 (12.9%)

40 (27.2%)

0.0003

ESR

21.7 (18.9)

28.5 (22.1)

0.0002

Swollen joint count

3.3 (4.2)

2.8 (3.9)

0.12

Damage joint count

1.1 (2.9)

7.6 (11.8)

<0.0001

Axial disease

67 (15.5%)

208 (90.4%)

<0.0001

Arthritis first

20 (4.6%)

21 (9.1%)

0.02

 


Disclosure:

A. Thavaneswaran,
None;

V. Chandran,
None;

D. D. Gladman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-patients-with-psoriatic-arthritis-fall-into-distinct-clinical-sub-groups-a-cluster-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology